Functional characterisation of components in two Plasmodium falciparum Cullin-RING-Ligase complexes
- Author(s)
- Marapana, D; Cobbold, SA; Pasternak, M; Shami, GJ; Ralph, SA; Lopaticki, S; Yousef, J; Vaibhav, V; Dagley, LF; Komander, D; Cowman, AF;
- Details
- Publication Year 2025-07-01,Volume 15,Issue #1,Page 21359
- Journal Title
- Scientific Reports
- Abstract
- Ubiquitination is the key eukaryotic post-translational modification that governs protein degradation, localisation, and activity which is mediated by a concerted enzyme cascade. The largest superfamily of these enzymes include the Cullin-RING-Ligase (CRL) complexes. Plasmodium falciparum, the causative agent of the most severe form of malaria in humans, encodes the critical proteins required for ubiquitination, but we do not yet understand the function of this pathway. Here the P. falciparum CRL complexes were characterised to reveal an essential but minimal repertoire controlled by two Cullin scaffolds. A PfCullin1-linked CRL complex, recruiting a single substrate receptor, was identified as being required for parasite inner-membrane biogenesis and DNA replication. A second CRL complex functioning through a PfCullin4 scaffold was identified that utilised a previously unidentified adaptor protein and receptors to support DNA replication. These results show that the P. falciparum CRL complexes are essential in both nuclear maintenance and membrane integrity.
- Publisher
- Springer Nature
- Keywords
- *Plasmodium falciparum/enzymology/metabolism/genetics; *Protozoan Proteins/metabolism/genetics; *Cullin Proteins/metabolism/genetics; DNA Replication; Humans; Ubiquitination
- Research Division(s)
- Infection and Global Health; Ubiquitin Signalling; Advanced Technology and Biology
- PubMed ID
- 40592953
- Publisher's Version
- https://doi.org/10.1038/s41598-025-05342-0
- Open Access at Publisher's Site
https://doi.org/10.1038/s41598-025-05342-0- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-07-28 08:47:53
Last Modified: 2025-07-28 08:48:02